Jun 18 |
Tivic Health: Christina Valauri Appointed to Board of Directors
|
May 22 |
Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications
|
May 16 |
Tivic Health Systems, Inc. (TIVC) Q1 2024 Earnings Call Transcript
|
May 15 |
Tivic Health Systems reports Q1 results
|
May 15 |
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
|
May 13 |
Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
|
May 13 |
Tivic Health Announces Closing of $4.0 Million Public Offering
|
May 9 |
Tivic Health Announces Pricing of $4.0 Million Public Offering
|
May 8 |
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems
|
Mar 28 |
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q4 2023 Earnings Call Transcript
|